Sequus, Prodesfarma S.A., Torrex Pharma Ges. m.b.H. deal

SEQU signed two exclusive agreements to market its Amphotec formulation of amphotericin B in several European countries to treat systemic fungal infections. Prodesfarma will exclusively distribute Am...